Euroapi SAS Current Deferred Revenue Over Time
| EAPI Stock | 2.12 0.04 1.92% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Euroapi SAS Performance and Euroapi SAS Correlation. Euroapi |
Cross Equities Current Deferred Revenue Analysis
Compare Euroapi SAS and related stocks such as Eurobio Scientific, Mediantechn, and Guerbet S A Current Deferred Revenue Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ALERS | 2.5 M | 2.5 M | 6.3 M | (648 K) | (692 K) | (633 K) | 191 K | 360 K | 156 K | 145 K | 179 K | 155 K | 438 K | 201 K | 201 K | 180.9 K | 171.9 K |
| ALMDT | (502.3 K) | (502.3 K) | (502.3 K) | (502.3 K) | (1.1 M) | 4.4 M | 4.4 M | 2.6 M | 4.7 M | 11.3 M | 13.3 M | 8.8 M | 8.1 M | 7.3 M | 7.3 M | 8.4 M | 6.5 M |
| GBT | (38.7 M) | (38.7 M) | (38.7 M) | (38.7 M) | (36.5 M) | (41 M) | (67 M) | (66.4 M) | (222.8 M) | 8.7 M | 8.1 M | 15 M | 19.4 M | 3.5 M | 3.5 M | 4 M | 4.2 M |
| LNA | 2.5 M | 2.5 M | 82 M | 84.5 M | 66.9 M | 41.8 M | 41 M | 50.2 M | 39 M | 37.8 M | 43 M | 58.3 M | 27.6 M | 3 M | 3 M | 2.7 M | 2.6 M |
| DBV | 0.0 | 0.0 | 217.2 K | 1.5 M | 1.7 M | 943.7 K | 3.6 M | 3.9 M | 6 M | 4.1 M | 5.7 M | 4.1 M | 2.1 M | 201.9 K | 201.9 K | 232.2 K | 220.5 K |
| ALCLS | 8.8 M | 0.0 | 0.0 | 7.7 M | 72.3 M | 59.9 M | 38.8 M | 26.1 M | 20.8 M | 20 M | 452 K | 301 K | 59 K | 110.3 M | 112.2 M | 129 M | 135.4 M |
| ALNOV | 116.9 K | 116.9 K | 116.9 K | 116.9 K | 886.3 K | 886.3 K | 1.3 M | 44.4 K | 253.3 K | 42.7 K | 60.9 M | 24.6 M | 608.6 K | 25.9 M | 25.9 M | 29.7 M | 31.2 M |
| ALSGD | 256 K | 256 K | 256 K | (876.6 K) | (1.1 M) | (137.4 K) | (130.3 K) | (1.9 M) | (1 M) | (3.1 M) | 73.4 K | 91.1 K | 34.7 K | 13.7 K | 13.7 K | 15.8 K | 16.6 K |
| AFME | 409 K | 409 K | 409 K | 409 K | 409 K | 409 K | 409 K | 409 K | 409 K | 409 K | 3.2 M | 9 K | 80 K | 80 K | 80 K | 72 K | 68.4 K |
| IPH | 597 K | 7.7 M | 7.7 M | 1.3 M | 885 K | (44.4 M) | 54.9 M | 47.9 M | 82.1 M | 48.8 M | 12.5 M | 12.5 M | 6.6 M | 5.9 M | 616 K | 708.4 K | 673 K |
Euroapi SAS and related stocks such as Eurobio Scientific, Mediantechn, and Guerbet S A Current Deferred Revenue description
Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.My Equities
My Current Equities and Potential Positions
| Euroapi SAS | EAPI |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 15 Rue Traversiere, |
| Exchange | Euronext Paris |
null 2.12
Other Information on Investing in Euroapi Stock
Euroapi SAS financial ratios help investors to determine whether Euroapi Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Euroapi with respect to the benefits of owning Euroapi SAS security.